Kisoji Biotechnology
Home - Kisoji Biotechnology Inc.
United States · $41.0M raised
- Business Model
- B2B
- Website
- kisojibiotech.com
- Total Funding
- $41.0M
- Last Round
- $41.0M Series BDec 2024
- Rounds
- 1
About
Antibody therapeutics company developing next-generation multi-specific antibody technologies for oncology.
Summary
Kisoji Biotechnology is a Biotech company based in United States. It has raised $41.0M in total across 1 round, most recently a $41.0M Series B round in Dec 2024. Investors include Lumira Ventures and Investissement Québec.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2024
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.